Wells Fargo & Company Liquidia Corp Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Liquidia Corp stock. As of the latest transaction made, Wells Fargo & Company holds 23,455 shares of LQDA stock, worth $258,239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,455
Previous 16,662
40.77%
Holding current value
$258,239
Previous $245,000
14.69%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LQDA
# of Institutions
162Shares Held
36MCall Options Held
1.79MPut Options Held
380K-
Patient Square Capital LP Menlo Park, CA7.18MShares$79.1 Million40.01% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$46.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$37.5 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.4MShares$26.4 Million13.89% of portfolio
-
State Street Corp Boston, MA2.23MShares$24.6 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $709M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...